Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

To determine the event-free survival (EFS) and overall survival of children with average-risk medulloblastoma and treated with reduced-dose craniospinal radiotherapy (CSRT) and one of two postradiotherapy chemotherapies.Four hundred twenty-one patients between 3 years and 21 years of age with nondis...

Full description

Saved in:
Bibliographic Details
Main Authors: Roger J. Packer, Amar Gajjar, Gilbert Vézina, Lucy B. Rorke‐Adams, Peter C. Burger, Patricia L. Robertson, Lisa A. Bayer, Deborah A. Lafond, Bernadine R. Donahue, MaryAnne Marymont, Karin M. Muraszko, James Langston, Richard Sposto
Format: Artigo
Language:English
Published: 2006
Online Access:https://doi.org/10.1200/jco.2006.06.4980
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.06.4980?role=tab
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1200/jco.2006.06.4980
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.06.4980?role=tab

Similar Items